Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zenicor Medical Systems ABXSAT:ZENI +2.15%50 Days Payable is 353.14 as of Mar. 2026, which is 1% below its 10-year median of 354.94. GuruFocus rates XSAT:ZENI with a GF Score™ of 50/100 and a GF Value™ of kr1.32 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Zenicor Medical Systems AB ranks better than 95.59% on this metric.
The historical rank and industry rank for Zenicor Medical Systems AB's Days Payable or its related term are showing as below:
XSAT:ZENI'
s Days Payable Range Over the Past 10 Years
Min: 65.47 Med: 354.94 Max: 1698.49
Current: 894.63
During the past 13 years, Zenicor Medical Systems AB's highest Days Payable was 1698.49. The lowest was 65.47. And the median was 354.94.
XSAT:ZENI's Days Payable is ranked better than 95.59% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs XSAT:ZENI: 894.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ZENI vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Zenicor Medical Systems AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenicor Medical Systems AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zenicor Medical Systems AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Zenicor Medical Systems AB's Days Payable falls into.
Zenicor Medical Systems AB Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenicor Medical Systems AB (XSAT:ZENI) has a Days Payable of 353.14 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenicor Medical Systems AB and its competitors. This is near median its historical median of 354.94. Over the past decade, Zenicor Medical Systems AB's Days Payable has ranged from 65.47 to 1,698.49. According to the industry distribution chart, Zenicor Medical Systems AB ranks #35 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 4.4%.
Is Zenicor Medical Systems AB's Days Payable too high?
Zenicor Medical Systems AB's current Days Payable of 353.14 is near median its 10-year median of 354.94. Over the past 10 years, this metric has ranged from a low of 65.47 to a high of 1,698.49. The Medical Devices & Instruments industry median Days Payable is 67.85. Zenicor Medical Systems AB's value of 353.14 is 420.5% above this industry median. Based on the distribution chart, Zenicor Medical Systems AB ranks #35 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zenicor Medical Systems AB has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenicor Medical Systems AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zenicor Medical Systems AB ranks #35 out of 794 companies for Days Payable. This places Zenicor Medical Systems AB in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.85. Zenicor Medical Systems AB's value of 353.14 is 420.5% above this benchmark. Historically, Zenicor Medical Systems AB's own Days Payable has ranged from 65.47 to 1,698.49 over the past decade. While the company's 10-year median is 354.94 vs. the industry median of 67.85, Zenicor Medical Systems AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenicor Medical Systems AB's current Days Payable of 353.14 is 420.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenicor Medical Systems AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenicor Medical Systems AB's current Days Payable is 353.14, which is near median its own 10-year median of 354.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenicor Medical Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Zenicor Medical Systems AB (XSAT:ZENI) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.32, compared to a current price of kr0.95 — trading 28% below its estimated fair value. The current Days Payable is 353.14, which is near median its 10-year median of 354.94 and 420.5% above the Medical Devices & Instruments industry median of 67.85. Zenicor Medical Systems AB's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zenicor Medical Systems AB (XSAT:ZENI), the current Days Payable is 353.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenicor Medical Systems AB (XSAT:ZENI) Overvalued in 2026?
Based on GuruFocus' analysis, Zenicor Medical Systems AB stock appears to be undervalued.
The current stock price of kr0.95 is trading 28% below its estimated GF Value™ of kr1.32.
GuruFocus considers Zenicor Medical Systems AB to be Modestly Undervalued.
Key valuation signals for XSAT:ZENI:
Days Payable: 353.14 (near median its 10-year median of 354.94)
GF Value™: kr1.32 vs. price of kr0.95 (28% below fair value)
Industry Position: 420.5% above the Medical Devices & Instruments median (#35 of 794)
No single metric tells the full story. See the XSAT:ZENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ZENI has been successfully added to your 
